Lantheus Holdings Beheer
Beheer criteriumcontroles 2/4
De CEO Lantheus Holdings is Brian Markison, benoemd in Mar2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0.025% van de aandelen van het bedrijf, ter waarde $ 1.37M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.7 jaar en 6.8 jaar.
Belangrijke informatie
Brian Markison
Algemeen directeur
US$539.1k
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | less than a year |
| Eigendom CEO | 0.02% |
| Management gemiddelde ambtstermijn | 1.7yrs |
| Gemiddelde ambtstermijn bestuur | 6.8yrs |
Recente managementupdates
Recent updates
Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem
Nov 13
Lantheus Holdings: Q3 Results Were Good But Market Overreacted
Nov 08Investors Still Waiting For A Pull Back In Lantheus Holdings, Inc. (NASDAQ:LNTH)
Nov 03Lantheus: PYLARIFY's Enhanced Prospects Are Welcome, But Don't Get Too Greedy Now
Oct 21Lantheus Holdings (NASDAQ:LNTH) Is Achieving High Returns On Its Capital
Oct 16We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease
Sep 28Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update)
Aug 12Here's Why Lantheus Holdings (NASDAQ:LNTH) Has Caught The Eye Of Investors
Aug 05Investors Appear Satisfied With Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Prospects As Shares Rocket 49%
Jul 17Lantheus Holdings (NASDAQ:LNTH) Is Investing Its Capital With Increasing Efficiency
Jul 16Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt
Jun 24Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus
May 23Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
May 10Lantheus Holdings: Powerful First Quarter
May 05Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital
Apr 12Lantheus Holdings: Undervalued With A Good Outlook
Feb 28Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
Feb 24Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly
Feb 08Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings
Jan 03Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing
Dec 16A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Nov 28Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?
Nov 09Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down
Sep 04Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Aug 09Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?
Jul 22Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively
May 29Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly
Apr 16Capital Allocation Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Ideal
Feb 27An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 48% Undervalued
Jan 16Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt
Dec 24Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively
Oct 31CEO
Brian Markison (65 yo)
less than a year
Tenure
US$539,112
Compensatie
Mr. Brian A. Markison has served as Chairman of the Board and Chief Executive Officer of Osmotica Pharmaceutical Corp. since 2016. Mr. Markison had been an Operating Executive and Healthcare Industry Execu...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | less than a year | US$539.11k | 0.025% $ 1.4m | |
| President | 1.7yrs | US$5.31m | 0.14% $ 7.9m | |
| CFO & Treasurer | 6.2yrs | US$4.33m | 0.16% $ 9.0m | |
| Chief Science Officer | less than a year | US$3.08m | 0.0083% $ 457.5k | |
| Chief Administrative Officer | 3.8yrs | US$3.12m | 0.11% $ 6.2m | |
| Chief Accounting Officer | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of Manufacturing & Technical Operations | 2.4yrs | geen gegevens | geen gegevens | |
| Chief Information Officer | less than a year | geen gegevens | geen gegevens | |
| Senior Director of Investor Relations | no data | geen gegevens | geen gegevens | |
| VP of Corporate Communications & Chief of Staff | 4.3yrs | geen gegevens | geen gegevens | |
| Chief People Officer | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of Quality | 6.6yrs | geen gegevens | geen gegevens |
1.7yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van LNTH wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.7 jaar), wat duidt op een nieuw team.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 12.2yrs | US$539.11k | 0.025% $ 1.4m | |
| Independent Director | 12.5yrs | US$493.31k | 0.087% $ 4.8m | |
| Independent Director | less than a year | geen gegevens | 0.0019% $ 107.0k | |
| Independent Director | 6.8yrs | US$483.39k | 0.045% $ 2.5m | |
| Chairman of the Board | 9.3yrs | US$12.58m | 0.84% $ 46.7m | |
| Independent Director | 2.7yrs | US$477.89k | 0.0043% $ 240.1k | |
| Independent Director | 4.4yrs | US$470.81k | 0.027% $ 1.5m | |
| Lead Independent Director | 7.8yrs | US$479.11k | 0.034% $ 1.9m | |
| Independent Director | 6.8yrs | US$493.31k | 0.029% $ 1.6m | |
| Independent Director | 4.4yrs | US$480.00k | 0.036% $ 2.0m |
6.8yrs
Gemiddelde duur
64.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van LNTH wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.8 jaar).